Literature DB >> 15364680

Monotherapy in epilepsy: role of the newer antiepileptic drugs.

Blanca Vazquez1.   

Abstract

BACKGROUND: Monotherapy is the goal for pharmacological treatment of epilepsy. Well-controlled trials have established the efficacy of some of the newer antiepileptic drugs (AEDs) as monotherapy.
OBJECTIVE: To review clinical data and expert opinions pertinent to the evaluation of most of the newer AEDs as monotherapy for epilepsy. DATA SOURCES: The MEDLINE database was searched for clinical trials using newer AEDs. Reference sections of review articles were manually searched to identify relevant studies not retrieved in MEDLINE. STUDY SELECTION: The resulting list of references was manually reviewed to identify monotherapy studies.
RESULTS: Lamotrigine and oxcarbazepine demonstrated efficacy in randomized active-control trials in patients with newly diagnosed epilepsy and in substitution trials in patients refractory to conventional AEDs.
CONCLUSION: Lamotrigine and oxcarbazepine are as effective as conventional AEDs at controlling partial seizures and are better tolerated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364680     DOI: 10.1001/archneur.61.9.1361

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents.

Authors:  Isabelle Beuchat; Jan Novy; Andrea O Rossetti
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

Review 2.  Economic analysis of newer antiepileptic drugs.

Authors:  Ettore Beghi; Lucia Atzeni; Livio Garattini
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Vigabatrin versus carbamazepine monotherapy for epilepsy.

Authors:  Yousheng Xiao; Lu Gan; Jin Wang; Man Luo; Hongye Luo
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18

4.  Characteristics of infantile convulsions and choreoathetosis syndrome caused by PRRT2 mutation.

Authors:  Yaxian Deng; Juanyu Xu; Chunmei Yao; Lei Wang; Xiaohuan Dong; Chengsong Zhao
Journal:  Pediatr Investig       Date:  2022-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.